DrugPatentWatch Database Preview
Details for Patent: 8,088,934
Which drugs does patent 8,088,934 protect, and when does it expire?
Patent 8,088,934 protects AMITIZA and is included in one NDA.
This patent has forty-five patent family members in twenty-four countries.
Summary for Patent: 8,088,934
| Title: | Composition and method for stabilizing the same |
| Abstract: | Disclosed is a novel composition comprising a novel bi-cyclic compound, which is expected to be pharmaceutically active, and a glyceride. The stability of the bi-cyclic compound can be improved significantly by dissolving the same in a glyceride. |
| Inventor(s): | Ueno; Ryuji (Montgomery, MD), Habe; Tsuyoshi (Sasayama, JP) |
| Assignee: | SUCAMPO AG (Zurich, CH) |
| Application Number: | 12/144,000 |
|
Patent Claim Types: see list of patent claims | Compound; |
Drugs Protected by US Patent 8,088,934
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sucampo Pharma Llc | AMITIZA | lubiprostone | CAPSULE;ORAL | 021908-002 | Apr 29, 2008 | RX | Yes | No | Start Trial | Start Trial | Y | Start Trial | ||||
| Sucampo Pharma Llc | AMITIZA | lubiprostone | CAPSULE;ORAL | 021908-001 | Jan 31, 2006 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,088,934
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 026046 | Start Trial | |||
| Argentina | 089848 | Start Trial | |||
| Argentina | 109354 | Start Trial | |||
| Austria | 267189 | Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
